News · Rocket Lab USA, Inc. (RKLB) · Industrials
Rocket Lab rises 2.7% as investors weigh Neutron delay and backlog report
What happened
Rocket Lab (RKLB) rose 2.7% on October 23 as investors digested company developments including a Neutron launch delay, a larger backlog and a reported cracked rocket tank. The stock closed at $52.60 after opening 1.0% below the previous close, in what the firm’s computed measure classed as an ordinary session for this stock. The S&P 500 fell 0.5% and the Industrials sector median fell 0.4%, leaving the stock’s performance 3.1 percentage points better than the sector median.
How big was the move
The day’s advance was modest by the company’s standards: the move was 0.7 times a typical daily move for this stock and trading volume was 0.6 times its 20-day average. Over the last five sessions the stock rose 3.5%. Rocket Lab’s market value stood at $31.48 billion and its beta is 2.83, meaning the stock tends to move more than the market.
The technical picture
Technically, the stock remained in a weak trend. The stock is 17.0% below its 20-day moving average, 20.7% below its 50-day moving average and 34.7% below its 200-day moving average, with the 50-day average below the 200-day average, a sign of a weak longer-term trend. The Relative Strength Index (14 days) was 33, inside a neutral range between 30 and 70. The share price is 65.2% below its 52-week high and has fallen 28.5% over one month, 21.4% over three months and 13.2% over one year, leaving it 27.0 percentage points behind the S&P 500 for the year. Volatility was 61% annualized over 60 days, lower than 80% of its own readings over five years.
Fundamentals and valuation
Over the four quarters through June 30, 2026, Rocket Lab reported revenue of $769.1 million, which grew 52.5% from a year earlier and showed growth of 45.8% versus one quarter earlier. Gross margin improved to 37.3% from 29.0% a year earlier, while operating margin was 29.1% versus 44.1% a year earlier. Diluted earnings per share was $-0.28 for the period. The company reported a free-cash-flow margin of 48.3% and return on invested capital of 5.3%. On the balance sheet, Rocket Lab had net cash of $2.00 billion.
The company’s free-cash-flow yield was 1.2% and share count over one year increased by 22.2%. Those figures underscore a company that is growing revenue quickly but operating at modest returns on invested capital and showing low free-cash-flow yield relative to typical value benchmarks. PromtFinance scores rank Rocket Lab highly for growth at 98 (Exceptional) but very weak on Value (11), Quality (8) and Stability (14), a mix that reflects rapid top-line expansion alongside a still-precarious profitability and capital structure profile.
Earnings and analyst expectations
Rocket Lab’s next report is scheduled for November 9, 2026. The last report, on August 10, 2026, showed earnings per share of $-0.08 against $-0.06 expected, a print 37.2% below estimates; the typical two-day reaction after recent reports has been that the stock fell 1.3%. The company has 0 consecutive quarters beating estimates, although its average surprise over the last four reports was 38.0% above estimates.
Twenty-one analysts cover the stock, with a consensus rating of Buy and 76% of analysts giving a Share rating the stock Buy or Strong Buy. The consensus price target is $105.17, which is 99.9% above the closing price. That gap between target and market price highlights the divergence between bullish analyst views on Rocket Lab’s growth prospects and the caution reflected in its recent price action and valuation metrics.
What to watch
- Oct. 14: Rocket Lab announced it is delaying the first launch of its Neutron rocket into 2027, without specifying a more precise launch date.
- A report noted Rocket Lab's backlog increased 137% year over year while its share price fell nearly 30% over a month and mentioned concerns about a cracked rocket tank, without further details or attribution.
- Next report: November 9, 2026 (quarterly earnings).
- Closing price on Oct. 23: $52.60; trading volume 0.6 times its 20-day average.
- Market value: $31.48 billion.